Peter Onyas

Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial.

T. Williams, K. Maitland, P. Olupot-Olupot, 2022, The Lancet. Infectious diseases.

Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo

C. Fanello, M. Mukaka, M. Onyamboko, 2023, BMC Medicine.

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria

A. Dondorp, C. Fanello, M. Imwong, 2023, EBioMedicine.